Testing Patterns for CKD-MBD Abnormalities in a Sample US Population
Introduction: Patterns of testing, treatment, and retesting following treatment for disorders of chronic kidney disease mineral bone disorder (CKD-MBD) have not been explored using a large electronic database. Methods: To determine concordance with CKD-MBD management guidelines, we used 2010 to 2019...
Main Authors: | James B. Wetmore, Yuanyuan Ji, Akhtar Ashfaq, David T. Gilbertson, Nicholas S. Roetker |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Kidney International Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024920318702 |
Similar Items
-
Effects of diuretics furosemide and hydrochlorothiazide on CKD-MBD: A prospective randomized study
by: Raquel F.V. Vasco, et al.
Published: (2021-06-01) -
Hiporrespuesta o resistencia a la acción de la hormona paratiroidea en la enfermedad renal crónica
by: Jordi Bover, et al.
Published: (2021-09-01) -
Effects of Normal Reference Range of Phosphorus and Corresponding PTH on Endothelial Function in CKD Patients
by: Shina Lee, et al.
Published: (2022-07-01) -
Parathyroid hormone as early marker of derangements of mineral metabolism among patients in various stages of chronic kidney disease
by: M. Rasheed Khan, et al.
Published: (2023-01-01) -
Evaluation of Serum 25‐Hydroxyvitamin D3 and Bone Mineral Density in 268 Patients with Hip Fractures
by: Shu‐jun Yu, et al.
Published: (2021-05-01)